Acuña, Mariana
Martínez, Pablo
Moraga, Carol
He, Xingxuan
Moraga, Mauricio
Hunter, Bessie
Nuernberg, Peter
Gutiérrez, Rodrigo A
González, Mauricio
Schuchman, Edward H
Luis Santos, José
Miquel, Juan Francisco
Mabe, Paulina
Zanlungo, Silvana
Article History
Received: 24 November 2014
Revised: 19 March 2015
Accepted: 25 March 2015
First Online: 29 April 2015
Competing interests
: EHS is an inventor on several patents licensed to Genzyme, a Sanofi Corporation, that describes the diagnosis and treatment of NPD. P Mabe has received a speaker honorarium form Genzyme, a Sanofi Corporation, and BioMarin. Also she has received support for assistance to scientific meetings from Genzyme, BioMarin and Shire. P Mabe and SZ have received research grants from Genzyme, a Sanofi Corporation. The remaining authors declare no conflict of interest.